- Report
- April 2023
- 120 Pages
Global
From €4533EUR$4,750USD£3,798GBP
- Report
- March 2024
- 150 Pages
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- November 2023
- 190 Pages
Global
From €4295EUR$4,500USD£3,598GBP
- Report
- December 2019
- 63 Pages
Global
From €3813EUR$3,995USD£3,195GBP
- Report
- February 2024
- 140 Pages
Vietnam
From €2662EUR$2,789USD£2,230GBP
- Report
- September 2022
- 104 Pages
Middle East, Africa
From €1432EUR$1,500USD£1,199GBP
- Report
- January 2024
- 200 Pages
Global
From €3961EUR$4,150USD£3,318GBP
- Report
- June 2023
- 577 Pages
Global
From €9539EUR$9,995USD£7,992GBP
- Report
- March 2023
- 479 Pages
Europe
From €8585EUR$8,995USD£7,193GBP
- Book
- December 2018
- 277 Pages
From €123EUR$129USD£103GBP
- Book
- April 2023
- 688 Pages
- Book
- February 2023
- 672 Pages
- Book
- September 2022
- 480 Pages
- Book
- July 2022
- 880 Pages
- Book
- August 2019
- 264 Pages
Coronary Artery Disease (CAD) is a type of cardiovascular disease that affects the arteries supplying blood to the heart. It is caused by the buildup of plaque in the arteries, which can lead to chest pain, heart attack, and other heart-related problems. CAD is one of the leading causes of death in the United States and other developed countries.
The CAD market within the context of cardiology is focused on the diagnosis, treatment, and prevention of the disease. Diagnostic tests such as electrocardiograms, echocardiograms, and cardiac catheterization are used to detect CAD. Treatment options include lifestyle changes, medications, and surgical procedures such as angioplasty and coronary artery bypass grafting. Prevention strategies include lifestyle modifications, medications, and regular check-ups.
Some companies in the CAD market include Abbott Laboratories, Boston Scientific, Medtronic, Johnson & Johnson, and St. Jude Medical. Show Less Read more
